Delivery Order SPE2DB25D3022-SPE2DB25FWCMS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $4,059.96. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the major pharmaceutical distributor. The contract has an ultimate completion date of September 15, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $2,885.35. This firm fixed-price delivery order, with a completion date of August 6, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was made on a competitive, non-set-aside basis and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,504.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pen injectors on July 22, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,628.68 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with an ultimate completion date of August 19, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $3,863.83 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a completion date of September 9, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award to the vendor. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, serving as the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens with a ceiling value of $4,883.67. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,514.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a $4,322.42 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml units). This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to a qualified pharmaceutical distributor. The contract is scheduled for completion by August 28, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWCMSDelivery Order
The Defense Logistics Agency awarded a $4,973.15 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 3 mg/0.5 mL pen auto-injectors. This contract, designated as a firm fixed price delivery order with an ultimate completion date of September 9, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was made through open competition with no set-aside designation, demonstrating AmerisourceBergen's continued capability to compete for federal healthcare commodities. Performance will be fulfilled from the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract serves as the vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems and related federal health programs worldwide. The Trulicity procurement exemplifies the breadth of specialty medications within AmerisourceBergen's federal portfolio, which includes diabetes treatments, neurological medications, pain management pharmaceuticals, and other critical medical commodities supporting Defense Health Agency operations and military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 9/8/25 |